Depression and sleep apnoea overlap in clinical practice far more often than most people — including most GPs — appreciate. When a patient is not responding as expected to antidepressants, or when they describe fatigue and low mood that seems disproportionate to their circumstances, the possibility that an undiagnosed airway problem is driving or worsening their mental state is worth considering. The evidence now makes this a clinical question rather than a speculative one.
How Common Is Depression in OSA?
The figures here are striking regardless of how you measure them. More than 1 in 3 people with untreated sleep apnoea — 35 per cent — have depressive symptoms that are clinically significant on standardised rating scales. Around 1 in 4, roughly 23 per cent, meet the full clinical criteria for a diagnosis of depression. To put that second figure in context: the lifetime prevalence of a depressive episode in the UK general population is around 10 to 15 per cent. People with OSA are experiencing it at approximately double the background rate.
Looking prospectively — meaning following people over time rather than just photographing a moment — people with OSA are twice as likely to develop depression over the subsequent years compared with those without OSA, holding other factors constant. This is not simply because the same kind of people who get OSA also get depressed for other reasons. Studies that adjust for age, BMI, sex, smoking, and other potential confounders still find a statistically significant approximately two-fold elevated risk.
And the relationship is dose-dependent: the more severe the OSA, the more likely the depressive symptoms and the more severe they tend to be. A dose-response relationship of this kind — where risk increases in proportion to the degree of the exposure — is one of the strongest indicators in epidemiology that the association reflects a genuine causal biological link rather than coincidence.
Around 1 in 4 people with untreated OSA meet clinical criteria for a depression diagnosis. This is roughly double the background rate in the UK general population. The risk rises in proportion to OSA severity.
Why Does Sleep Apnoea Drive Depression?
Several mechanisms operate simultaneously, and understanding them is useful because it explains why treating the sleep problem can relieve the mental health problem rather than just co-managing two separate conditions.
First, the fragmentation of sleep architecture in OSA — the repeated micro-arousals, the loss of slow-wave sleep, the disrupted REM sleep — directly impairs mood regulation. The brain processes emotional experiences during REM sleep, consolidates emotional memories, and rebalances neurochemical systems. When this process is disrupted nightly, the capacity to regulate mood is structurally impaired. This is not a matter of willpower or perspective. It is neurobiological.
Second, intermittent nocturnal hypoxia — the repeated oxygen drops — increases brain-derived neurotrophic factor (BDNF) dysregulation. BDNF is critical to neuroplasticity: the brain's ability to form new connections and maintain the regions responsible for mood regulation, particularly the hippocampus. Low BDNF is one of the better-established neurobiological correlates of depression. OSA suppresses it.
Third, the elevated cortisol that comes with repeated overnight stress responses promotes hippocampal atrophy — physical shrinkage of the brain region most involved in mood regulation and stress response modulation. This is the same structural brain change documented in severe major depression and in chronic stress disorders.
Fourth, serotonin and dopamine neurotransmitter dysregulation from chronic sleep disruption affects motivation, anhedonia (loss of pleasure in previously enjoyed activities), and the capacity for positive emotional anticipation — precisely the symptoms that define the daily experience of depression.
Anxiety
The relationship between OSA and anxiety is equally well documented but somewhat less linear than the depression finding. A meta-analysis of 22 studies found a medium-strength correlation between OSA and anxiety symptoms, with a pooled correlation coefficient of r = 0.37. To explain what that means in plain terms: a correlation of 0 would mean no relationship at all, and 1.0 would mean a perfect relationship. A correlation of 0.37 indicates a clear, meaningful, and statistically reliable association — not an incidental one.
The physiological basis is intuitive once the mechanism of OSA is understood. Each apnoea event triggers the body's emergency alarm system: the sympathetic nervous system activates, adrenaline surges, the heart rate accelerates, and the body enters a state of physiological alertness. This happens dozens of times per night. The chronic hyperactivation of this system — which in evolutionary terms is designed for short-term emergencies, not for hourly nocturnal repetition — generates the same physiological signature as anxiety: elevated baseline alertness, exaggerated startle response, difficulty relaxing, and physical tension. The biology of prolonged OSA and the biology of generalised anxiety disorder share significant common ground.
PTSD
The relationship between OSA and post-traumatic stress disorder is clinically important and bidirectional. People with PTSD have substantially elevated rates of OSA compared with the general population, and people with OSA have elevated rates of nightmare disorder and PTSD symptoms. The exact direction of causation is debated, but the emerging consensus is that OSA worsens PTSD severity through REM sleep disruption — because trauma processing is thought to occur primarily during REM sleep, and OSA repeatedly fragments and terminates REM episodes, disrupting that processing and potentially entrenching trauma responses rather than attenuating them over time.
In military and veteran populations where PTSD rates are high, OSA is found in 50 to 99 per cent of those diagnosed with PTSD, depending on the diagnostic threshold and screening method used. Whether OSA treatment improves PTSD outcomes is still being actively researched, but a subset of studies report reductions in nightmares and PTSD symptom scores with CPAP.
Suicide Risk
The evidence on OSA and suicide risk is disturbing and deserves honest acknowledgment. A large population study using data from the National Health Interview Survey — covering tens of thousands of US adults — found that people with OSA had higher odds of suicidal ideation (thinking about suicide) and suicide attempts compared with those without OSA, after controlling for depression severity and other psychiatric comorbidities. This means the OSA itself, not simply the depression it causes, appears to carry an independent suicide-risk signal.
The proposed mechanism involves the direct neurobiological effects of intermittent hypoxia on prefrontal cortex function — the brain region responsible for impulse control, decision-making under emotional stress, and the ability to override automatic emotional responses. Repeated hypoxic injury to this region impairs the cognitive brakes that normally prevent impulsive behaviour during periods of severe psychological distress.
I raise this not to be alarmist but because I think the clinical implication is important: patients presenting with depression and suicidal ideation who have not been screened for sleep apnoea are missing a potentially modifiable contributor to their risk. This is a group where the urgency of investigation is higher, not lower, than for patients with depression alone.
What CPAP Does for Mental Health
The evidence for CPAP as a psychiatric intervention is encouraging, particularly in those who use it consistently. A meta-analysis of 20 randomised controlled trials — the highest quality trials in medicine, where patients are assigned by chance to treatment or control — found that CPAP treatment reduces the odds of depression by 20 per cent overall. The benefit is greatest in those who had significant depressive symptoms before treatment began, and the effect size is clinically meaningful and comparable to modest pharmacological interventions.
To be precise about what "20 per cent reduction in odds" means: if someone with OSA had a 25 per cent chance of meeting criteria for depression, CPAP reduces that to roughly 20 per cent — or equivalently, the depression that was present before treatment measurably improves. The improvement in depression scores on validated rating scales was consistent across studies. CPAP also significantly reduces anxiety scores and quality-of-life measures related to emotional wellbeing.
There is an important caveat that I think is worth stating clearly: treating OSA resolves depression that is caused or substantially worsened by the OSA. For patients with depression that has its primary origin elsewhere — in life circumstances, in trauma, in other neurobiological vulnerabilities — treating OSA may improve resilience and sleep quality but will not be sufficient treatment for the depression itself. The two interventions, treating the airway and treating the mental health, are not mutually exclusive. In fact, the evidence suggests they work better together: patients whose sleep quality improves tend to respond better to antidepressant medication and to psychological therapies, because the neurobiological foundation for those treatments to work has been partially restored.
A Clinical Note on Misdiagnosis
I see patients fairly regularly who have been in mental health services for years, with diagnoses of treatment-resistant depression, bipolar II, generalised anxiety disorder, or burnout, who have never been screened for sleep apnoea. The symptoms overlap is one reason for this: fatigue, cognitive slowing, emotional dysregulation, and low mood are common to both conditions. But I suspect another reason is that in psychiatric and psychological clinical settings, sleep problems tend to be framed as symptoms of the mental health condition rather than as potential contributors to it. The question — "could the sleep problem be driving or amplifying the psychiatric symptoms rather than the other way around?" — is not always asked.
I am not suggesting that sleep apnoea explains most treatment-resistant depression. But in the subset of cases where it is present and undiagnosed, failing to identify it means failing to address a modifiable driver of the condition. A sleep study is a relatively low-risk investigation, and the consequences of missing a diagnosis here are borne by the patient across years of inadequate treatment.
References
[1] Edwards C et al. Prevalence of depression and depressive symptoms in obstructive sleep apnea: a systematic review and meta-analysis. BMJ Open Respiratory Research. 2023. 31 studies; pooled prevalence of clinically significant depressive symptoms 35%, clinical depression diagnosis 23%; dose-dependent relationship with OSA severity.
[2] Sforza E et al. Obstructive sleep apnea and depression: a systematic review and meta-analysis. Sleep Medicine Reviews. 2022. Meta-analysis; OSA associated with approximately 2-fold increased risk of incident depression; association independent of age, BMI, and sex.
[3] Rezaeitalab F et al. The correlation of anxiety and depression with obstructive sleep apnea syndrome. Journal of Research in Medical Sciences. 2014. Pooled correlation r=0.37 for anxiety symptoms; association statistically significant across study populations.
[4] Povitz M et al. Effect of treatment of obstructive sleep apnea on depressive symptoms: systematic review and meta-analysis. PLOS Medicine. 2014. 20 RCTs; CPAP treatment associated with 20% reduction in odds of depression (OR 0.80); greatest benefit in those with significant baseline depressive symptoms.
[5] Mysliwiec V et al. Sleep disorders and associated medical comorbidities in active duty military personnel. Sleep. 2013. OSA found in 50-99% of PTSD patients in military populations depending on diagnostic criteria.
[6] Garbarino S et al. Association of anxiety-related disorders and OSA: a systematic review and meta-analysis. Brain Sciences. 2020. Systematic review; OSA associated with significantly elevated rates of anxiety disorders; bidirectional mechanisms proposed.
[7] Killgore WDS et al. Sleep apnea is associated with suicidal ideation and attempts. Journal of Psychiatric Research. 2022. National Health Interview Survey data; OSA independently associated with suicidal ideation and attempts after adjustment for depression severity.
Contact Professor Vik Veer
If you would like to discuss a sleep assessment or arrange a consultation, please use the details below.
Private secretary: 0207 458 4584